Copyright
©The Author(s) 2019.
World J Gastroenterol. Oct 7, 2019; 25(37): 5619-5629
Published online Oct 7, 2019. doi: 10.3748/wjg.v25.i37.5619
Published online Oct 7, 2019. doi: 10.3748/wjg.v25.i37.5619
Table 1 Diagnostic criteria of pancreatic cancer
| Diagnostic criteria | Methods | Positive finding |
| Definite criteria | ||
| Pathologic analysis | Endoscopy, ERCP, EUS-FNA, Surgery | Adenocarcinoma Mucinous carcinoma Adenosquamous carcinoma Other malignant neoplasm |
| Possible criteria | ||
| Imaging finding | CT, MRI, ERCP, MRCP, EUS, endoscopy, PET | Focal hypo-attenuated lesion Pancreatic duct dilation Distal pancreatic parenchymal atrophy Involvement of the surrounding vascular structures or other organs |
| Clinical features | Medical record | Clinical courses compatible with PC |
| Tumor marker | CA19-9 | > 100 U/mL |
| αFP | To exclude other malignancies including hepatocellular carcinoma | |
Table 2 Cancer cell type of pancreatic cancer
| Adenocarcinoma | Adeno-squamouscarcinoma | Neuroendocrinetumor | Total | |
| C250 | 163 | 0 | 1 | 164 |
| C251 | 33 | 0 | 0 | 33 |
| C252 | 45 | 0 | 0 | 45 |
| C253 | 2 | 0 | 0 | 2 |
| C254 | 2 | 0 | 0 | 2 |
| C257 | 1 | 0 | 0 | 1 |
| C259 | 640 | 3 | 14 | 657 |
| 886 (98.0)1 | 3 (0.3) | 15 (1.7) | 904 |
Table 3 Characteristics of patients with pancreatic cancer according to the international classification of diseases, 10th revision edition
| Parameters | N (%) | C250 | C251 | C252 | C253 | C254 | C257 | C259 |
| Number of patients | 1846 | 234 (12.7)2 | 72 (3.9) | 104 (5.6) | 5 (0.3) | 2 (0.1) | 1 (0.1) | 1428 (77.4) |
| Age at diagnosis | 65.22 ± 11.971 | 64.72 ± 10.14 | 63.39 ± 10.48 | 65.43 ± 11.32 | 65.20 ± 11.08 | 70.50 ± 4.95 | 45.00 ± 0.00 | 65.39 ± 12.35 |
| Gender (male: Female) | 1116:730 | 150:84 | 45:27 | 52:52 | 1:4 | 2:0 | 1:0 | 865:563 |
| Diagnostic criteria | ||||||||
| Definite | 910 (49.3) | 164 (70.1) | 34 (47.2) | 45 (43.3) | 2 (40.0) | 2 (100.0) | 1 (100.0) | 662 (46.4) |
| Possible | 936 (50.7) | 70 (29.9) | 38 (52.8) | 59 (56.7) | 3 (60.0) | 0 (0.0) | 0 (0.0) | 766 (53.6) |
| Methods of pathologic diagnosis (n = 910) | ||||||||
| ERCP or endoscopy | 163 (17.9) | 34 (20.7) | 2 (5.9) | 8 (17.8) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 119 (18.0) |
| EUS-FNA or percutaneous biopsy | 30 (3.3) | 4 (2.4) | 0 (0.0) | 2 (4.4) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 26 (3.9) |
| Surgery | 717 (78.8) | 126 (76.8) | 32 (94.1) | 35 (77.8) | 2 (100.0) | 2 (100.0) | 1 (100.0) | 517 (78.1) |
| CA19-9 > 100 U/L | ||||||||
| Yes | 684 (37.1) | 95 (40.6) | 29 (40.3) | 44 (42.3) | 1 (20.0) | 0 (0.0) | 0 (0.0) | 515 (36.1) |
| No | 514 (27.8) | 63 (26.9) | 24 (33.3) | 23 (22.1) | 1 (20.0) | 1 (50.0) | 0 (0.0) | 402 (28.2) |
| Missing | 648 (35.1) | 76 (32.5) | 19 (26.4) | 37 (35.6) | 3 (60.0) | 1 (50.0) | 1 (100.0) | 511 (35.8) |
Table 4 Diagnostic accuracy of pancreatic cancer diagnosed by the international classification of diseases, 10th revision edition in the administrative database
| Status of PC | Total | |||
| Positive | Negative | |||
| Definite diagnostic criteria | ||||
| ICD codes of PC | Outcome positive | True positive | False positive | 910 |
| 904 | 6 | |||
| Outcome negative | False negative | True negative | 1846 | |
| 1 | 1845 | |||
| Total | 905 | 1851 | 2756 | |
| Possible diagnostic criteria | ||||
| ICD codes of PC | Outcome positive | True positive | False positive | 936 |
| 918 | 18 | |||
| Outcome negative | False negative | True negative | 1846 | |
| 1 | 1845 | |||
| Total | 919 | 1863 | 2782 | |
| Overall diagnostic criteria | ||||
| ICD codes of PC | Outcome positive | True positive | False positive | 1846 |
| 1822 | 24 | |||
| Outcome negative | False negative | True negative | 1846 | |
| 1 | 1845 | |||
| Total | 1823 | 1869 | 3692 | |
Table 5 Diagnostic accuracy of pancreatic cancer according to tumor sites by the international classification of diseases, 10th revision edition
Table 6 Diagnostic power of international classification of diseases, 10th revision edition for pancreatic cancer
| Overall diagnosis | Definite diagnosis | Possible diagnosis | ||||
| Point estimate (%) | 95%CI (%) | Point estimate (%) | 95%CI (%) | Point estimate (%) | 95%CI (%) | |
| Sensitivity | 99.95 | 99.94-99.95 | 99.89 | 99.88-99.90 | 99.89 | 99.88-99.90 |
| Specificity | 98.72 | 98.70-98.73 | 99.68 | 99.67-99.68 | 99.03 | 99.02-99.05 |
| Positive predictive value | 98.70 | 98.68-98.72 | 99.34 | 99.32-99.36 | 98.08 | 98.05-98.11 |
| Negative predictive value | 99.95 | 99.94-99.95 | 99.95 | 99.94-99.95 | 99.95 | 99.94-99.95 |
- Citation: Hwang YJ, Park SM, Ahn S, Lee JC, Park YS, Kim N. Accuracy of an administrative database for pancreatic cancer by international classification of disease 10th codes: A retrospective large-cohort study. World J Gastroenterol 2019; 25(37): 5619-5629
- URL: https://www.wjgnet.com/1007-9327/full/v25/i37/5619.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i37.5619
